Literature DB >> 28088012

New 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies.

Milan M Milutinović1, Ana Rilak2, Ioannis Bratsos3, Olivera Klisurić4, Milan Vraneš5, Nevenka Gligorijević6, Siniša Radulović6, Živadin D Bugarčić7.   

Abstract

In this study, we have developed a series of new monofunctional Ru(II) complexes of the general formula mer-[Ru(Cl-Ph-tpy)(N-N)Cl]Cl in which Cl-Ph-tpy is 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine, N-N is a bidentate chelating ligand (1,2-diaminoethane (en, 1), 1,2-diaminocyclohexane (dach, 2) or 2,2'-bipyridine (bpy, 3)). All complexes were fully characterized by elemental analysis and spectroscopic techniques (IR, UV-Vis, 1D and 2D NMR). Their chemical behavior in aqueous solution was studied by UV-Vis and NMR spectroscopy showing that all compounds are relatively labile leading to the formation of the corresponding aqua species 1aq-3aq. Their DNA binding ability was evaluated by UV-Vis spectroscopy, fluorescence quenching measurements and viscosity measurements. Competitive studies with ethidium bromide (EB) showed that the complexes can displace DNA-bound EB, suggesting strong competition with EB (Ksv=1.1-2.7×104M-1). These experiments show that the ruthenium complexes interact with DNA via intercalation. The complexes bind to serum protein albumin displaying relatively high binding constants (Ksv=104-105M-1). Compound 3 displayed from high to moderate cytotoxicity against two cancer cell lines HeLa and A549 (with IC50ca. 12.7μM and 53.8μM, respectively), while complexes 1 and 2 showed only moderate cytotoxicity (with IC50ca. 84.8μM and 96.3μM, respectively) against HeLa cells. The cell cycle analysis (by flow cytometry) of HeLa and A549 cells treated with complex 3 shows minor changes on the cell cycle phase distribution.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Albumin; Cytotoxicity; DNA; Meridional; Ru(II) complexes; Substituted terpyridine

Mesh:

Substances:

Year:  2016        PMID: 28088012     DOI: 10.1016/j.jinorgbio.2016.10.001

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  Antimicrobial Activity and DNA/BSA Binding Affinity of Polynuclear Silver(I) Complexes with 1,2-Bis(4-pyridyl)ethane/ethene as Bridging Ligands.

Authors:  Sonja Ž Đurić; Sandra Vojnovic; Tina P Andrejević; Nevena Lj Stevanović; Nada D Savić; Jasmina Nikodinovic-Runic; Biljana Đ Glišić; Miloš I Djuran
Journal:  Bioinorg Chem Appl       Date:  2020-04-14       Impact factor: 7.778

2.  Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.

Authors:  Petar Čanović; Ana Rilak Simović; Snežana Radisavljević; Ioannis Bratsos; Nicola Demitri; Marina Mitrović; Ivanka Zelen; Živadin D Bugarčić
Journal:  J Biol Inorg Chem       Date:  2017-07-10       Impact factor: 3.358

3.  Synthesis, substitution kinetics, DNA/BSA binding and cytotoxicity of tridentate N^E^N (E = NH, O, S) pyrazolyl palladium(II) complexes.

Authors:  Reinner O Omondi; Adewale O Fadaka; Amos A Fatokun; Deogratius Jaganyi; Stephen O Ojwach
Journal:  J Biol Inorg Chem       Date:  2022-10-05       Impact factor: 3.862

4.  A novel ruthenium complex with xanthoxylin induces S-phase arrest and causes ERK1/2-mediated apoptosis in HepG2 cells through a p53-independent pathway.

Authors:  Nanashara C de Carvalho; Sara P Neves; Rosane B Dias; Ludmila de F Valverde; Caroline B S Sales; Clarissa A G Rocha; Milena B P Soares; Edjane R Dos Santos; Regina M M Oliveira; Rose M Carlos; Paulo C L Nogueira; Daniel P Bezerra
Journal:  Cell Death Dis       Date:  2018-01-23       Impact factor: 8.469

5.  Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.

Authors:  Maja Savic; Aleksandar Arsenijevic; Jelena Milovanovic; Bojana Stojanovic; Vesna Stankovic; Ana Rilak Simovic; Dejan Lazic; Nebojsa Arsenijevic; Marija Milovanovic
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.